Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker INV
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Bruce Brown Director | INV Innventure, Inc. | Buy | 30,000 | $1.51 | $45.3K Buy | Form 4 ↗ |
| Aug 20, 2026 | Gregory W. Haskell Chief Executive Officer, Director | INV Innventure, Inc. | Buy | 50,000 | $1.51 | $75.5K Buy | Form 4 ↗ |
| Aug 20, 2026 | Michael Otworth Executive Chairman, Director | INV Innventure, Inc. | Buy | 231,000 | $1.51 | $348.8K Buy | Form 4 ↗ |
| Aug 20, 2026 | James O. Donnally Director | INV Innventure, Inc. | Buy | 225,000 | $1.50 | $337.5K Buy | Form 4 ↗ |
| Apr 20, 2026 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 582,139 | $5.52 | $3.2M Sale | Form 4 ↗ |
| Apr 14, 2026 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 2,992 | $5.01 | $15.0K Sale | Form 4 ↗ |
| Dec 18, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 252,502 | $4.68 | $1.2M Sale | Form 4 ↗ |
| Dec 17, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 184,777 | $4.86 | $898.0K Sale | Form 4 ↗ |
| Dec 4, 2025 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 55,840 | $5.19 | $289.8K Sale | Form 4 ↗ |
| Dec 3, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 172,589 | $4.76 | $821.5K Sale | Form 4 ↗ |
| Dec 2, 2025 | Michael Otworth Executive Chairman, Director | INV Innventure, Inc. | Buy | 12,000 | $5.06 | $60.7K Buy | Form 4 ↗ |
| Dec 2, 2025 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 8,450 | $5.01 | $42.3K Sale | Form 4 ↗ |
| Dec 2, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 117,901 | $4.95 | $583.6K Sale | Form 4 ↗ |
| Dec 1, 2025 | Roland Austrup Chief Growth Officer | INV Innventure, Inc. | Buy | 4,900 | $5.01 | $24.5K Buy | Form 4 ↗ |
| Dec 1, 2025 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 81,993 | $5.13 | $420.6K Sale | Form 4 ↗ |
| Dec 1, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 427,301 | $5.11 | $2.2M Sale | Form 4 ↗ |
| Nov 26, 2025 | Gregory W. Haskell Chief Executive Officer, Director | INV Innventure, Inc. | Buy | 10,000 | $5.14 | $51.4K Buy | Form 4 ↗ |
| Nov 26, 2025 | John Stewart Scott Chief Strategy Officer | INV Innventure, Inc. | Sale | 452,668 | $5.13 | $2.3M Sale | Form 4 ↗ |
| Nov 25, 2025 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 266,367 | $5.31 | $1.4M Sale | Form 4 ↗ |
| Nov 21, 2025 | James O. Donnally Director | INV Innventure, Inc. | Buy | 27,886 | $3.37 | $94.0K Buy | Form 4 ↗ |
| Nov 20, 2025 | Suzanne Niemeyer Director | INV Innventure, Inc. | Buy | 4,000 | $3.40 | $13.6K Buy | Form 4 ↗ |
| Nov 20, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 302,211 | $3.51 | $1.1M Sale | Form 4 ↗ |
| Nov 19, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 235,765 | $3.34 | $787.5K Sale | Form 4 ↗ |
| Nov 18, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 263,782 | $3.61 | $952.3K Sale | Form 4 ↗ |
| Oct 29, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 149,708 | $2.92 | $437.1K Sale | Form 4 ↗ |
| Oct 27, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 98,167 | $2.97 | $291.6K Sale | Form 4 ↗ |
| Oct 24, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 263,627 | $3.03 | $798.8K Sale | Form 4 ↗ |
| Oct 23, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 193,587 | $3.13 | $605.9K Sale | Form 4 ↗ |
| Oct 22, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 436,296 | $3.01 | $1.3M Sale | Form 4 ↗ |
| Oct 10, 2025 | We-Inn LLC 10% owner | INV Innventure, Inc. | Sale | 2,300 | $3.92 | $9,016 Sale | Form 4 ↗ |
| Oct 9, 2025 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 10,828 | $5.21 | $56.4K Sale | Form 4 ↗ |
| Oct 8, 2025 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 8,606 | $5.05 | $43.5K Sale | Form 4 ↗ |
| Oct 7, 2025 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 500 | $5.01 | $2,505 Sale | Form 4 ↗ |
| Oct 6, 2025 | Daniel J. Hennessy Director | INV Innventure, Inc. | Sale | 6,265 | $5.11 | $32.0K Sale | Form 4 ↗ |
34 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:02 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances